These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29710478)

  • 41. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation.
    Treuter E; Venteclef N
    Biochim Biophys Acta; 2011 Aug; 1812(8):909-18. PubMed ID: 21172431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear Receptors in Hepatic Glucose and Lipid Metabolism During Neonatal and Adult Life.
    Cai D; Liu H; Zhao R
    Curr Protein Pept Sci; 2017; 18(6):548-561. PubMed ID: 27356935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat.
    Guéguen Y; Souidi M; Baudelin C; Dudoignon N; Grison S; Dublineau I; Marquette C; Voisin P; Gourmelon P; Aigueperse J
    Arch Toxicol; 2006 Apr; 80(4):187-95. PubMed ID: 16231126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility.
    Koutsounas I; Theocharis S; Delladetsima I; Patsouris E; Giaginis C
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):523-32. PubMed ID: 25553772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats.
    Ji W; Gong BQ
    J Ethnopharmacol; 2008 Sep; 119(2):291-8. PubMed ID: 18691646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classical nuclear hormone receptor activity as a mediator of complex biological responses: a look at health and disease.
    Yen PM
    Best Pract Res Clin Endocrinol Metab; 2015 Aug; 29(4):517-28. PubMed ID: 26303080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Herbal Induced Hepatoprotection and Hepatotoxicity: A Critical Review.
    Bedi O; Bijjem KRV; Kumar P; Gauttam V
    Indian J Physiol Pharmacol; 2016; 60(1):6-21. PubMed ID: 29953177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR.
    Liddle C; Goodwin B
    Semin Liver Dis; 2002; 22(2):115-22. PubMed ID: 12016543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear Receptor-Mediated Hepatomegaly and Liver Regeneration: An Update.
    Zhao P; Fan S; Gao Y; Huang M; Bi H
    Drug Metab Dispos; 2022 May; 50(5):636-645. PubMed ID: 35078806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FXR: a promising target for the metabolic syndrome?
    Cariou B; Staels B
    Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
    Kim YC; Fang S; Byun S; Seok S; Kemper B; Kemper JK
    Hepatology; 2015 Jul; 62(1):220-31. PubMed ID: 25545350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear receptors in regenerating liver and hepatocellular carcinoma.
    Vacca M; Degirolamo C; Massafra V; Polimeno L; Mariani-Costantini R; Palasciano G; Moschetta A
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):108-19. PubMed ID: 22789748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors.
    Chiang JY
    Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G349-56. PubMed ID: 12576301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential.
    Verreault M; Kaeding J; Caron P; Trottier J; Grosse L; Houssin E; Pâquet S; Perreault M; Barbier O
    Drug Metab Rev; 2010 Feb; 42(1):110-22. PubMed ID: 19831728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functions of Cholesterol Metabolites.
    Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S151-3. PubMed ID: 26598835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear Receptors as Autophagy-Based Antimicrobial Therapeutics.
    Silwal P; Paik S; Jeon SM; Jo EK
    Cells; 2020 Aug; 9(9):. PubMed ID: 32867365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear receptors in the kidney during health and disease.
    Libby AE; Jones B; Lopez-Santiago I; Rowland E; Levi M
    Mol Aspects Med; 2021 Apr; 78():100935. PubMed ID: 33272705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional Regulation of Hepatic Autophagy by Nuclear Receptors.
    Kim EY; Lee JM
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.